Clinical Trial Update: Mepolizumab for Eosinophilic Fasciitis [Phase 1]

View source ↗

Summary

A Phase 1 clinical trial evaluating mepolizumab for eosinophilic fasciitis has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Eosinophilic Fasciitis

Drugs mentioned

• Mepolizumab (mepolizumab)

Snippet

Sponsor: Mayo Clinic | Conditions: Eosinophilic Fasciitis | Phase 1 | Status: WITHDRAWN